Leukocyte pyruvate kinase expression is reduced in normal human pregnancy but not in pre-eclampsia

American Journal of Reproductive Immunology

Volumn 64, Issue 2, 2010, Pages 137-151

  Xu, Yi ^a   Madsen Bouterse, Sally A ^b   Romero, Roberto ^a,b   Hassan, Sonia ^a   Mittal, Pooja ^a   Elfline, Megan ^c   Zhu, Aiping ^c   Petty, Howard R ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Lymphocytes; Neutrophils; Signaling

Indexed keywords

CALCIUM ION; PYRUVATE KINASE; PYRUVIC ACID;

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKOCYTE; LYMPHOCYTE; NEUTROPHIL; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ADULT; BLOOD; CALCIUM SIGNALING; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; FLUOROIMMUNOASSAY; IMMUNOLOGY; JURKAT CELL LINE; METABOLISM; THIRD TRIMESTER PREGNANCY;

ADULT; CALCIUM SIGNALING; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; GLYCOLYSIS; HUMANS; JURKAT CELLS; LEUKOCYTES; MICROSCOPY, FLUORESCENCE; NEUTROPHILS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PYRUVATE KINASE; PYRUVIC ACID;

EID: 77958088846     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00881.x     Document Type: Article

References (78)

1. Brabin BJ: Epidemiology of infection in pregnancy. Rev Infect Dis 1985; 7:579-603
2. Larsen B, Galask RP: Host-parasite interactions during pregnancy. Obstet Gynecol Surv 1978; 33:297-318
3. Reinhardt MC: Effects of parasitic infections in pregnant women. Ciba Found Symp 1979; 77:149-170.
4. Luft BJ, Remington JS: Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice. Infect Immun 1982; 38:1164-1171.
5. Cunningham FG, Leveno KJ, Hankins GDV, Whalley PJ: Respiratory insufciency associated with pyelonephritis during pregnancy. Obstet Gynecol 1984; 63:121-125.
6. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356
7. Miyaura H, Iwata M: Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002; 168:1087-1094.
8. Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW: Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia 2007; 50:2147-2155.
9. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T: Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-291.
10. Spector TD, da Silva JAP: Pregnancy and rheumatoid arthritis. Clin Rheumatol 1992; 11:189-194.
11. Agarwal RK, Chan C-C, Wiggert B, Caspi RR: Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J Immunol 1999; 162:2648-2654.
12. Kaaja RJ, Greer IA: Manifestations of chronic disease during pregnancy. JAMA 2005; 294:2751-2757.
13. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S: Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22:234-241.
14. Cotton DJ, Seligmann B, O'Brian B, Gallin JI: Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy. J Infect Dis 1983; 148:194-199.
15. Tsukimori KI, Maeda H, Ishida K, Nagata H, Koyanagi T, Nadano H: The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol 1993; 81:536-540.
16. Benjamin JL, Remington JS: The adverse effect of pregnancy on macrophage activation. Cell Immunol 1984; 85:94-99.
17. El-Maallem H, Fletcher J: Impaired neutrophil function and myeloperoxidase deciency in pregnancy. Br J Haematol 1980; 44:375-381.
18. Bjoksten B, Soderstrom T, Damber MG, Von Schoultz B, Stigbrand T: Polymorphonuclear leucocyte function during pregnancy. Scand J Immunol 1978; 8:257-262.
19. Krause PJ, Ingardia CJ, Pontius LT, Malech HL, Lobello TM, Maderazo EG: Host defense during pregnancy: neutrophil chemotaxis and adherence. Am J Obstet Gynecol 1987; 157:274-280.
20. Persellin RH, Thoi LL: Human polymorphonuclear leukocyte phagocytosis in pregnancy: development of inhibition during gestation and recovery in the post partum period. Am J Obstet Gynecol 1979; 134:250-255.
21. Matarese G, La Cava A: The intricate interface between immune system and metabolism. Trends Immunol 2004; 25:193-200.
22. Kindzelskii AL, Eszes MM, Todd RF, Petty HR: Proximity oscillations of complement receptor type 4 and urokinase receptors on migrating neutrophils are linked with signal transduction /metabolic oscillations. Biophys J 1997; 73:1777-1784.
23. Reynolds JM, Liu Q, Brittingham KC, Liu Y, Gruenthal M, Gorgun CZ, Hotamisligil GS, Stout RD, Suttles J: Deciency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J Immunol 2007; 179:313-321.
24. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R: mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460:108-112.
25. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y: Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460:103-107.
26. Petty HR, Kindzelskii A, Espinoza J, Romero R: Trophoblast contact de-activates human neutrophils. J Immunol 2006; 176:3205-3214.
27. Bakowski D, Parekh AB: Regulation of store-operated calcium channels by the intermediary metabolite pyruvic acid. Curr Biol 2007; 17:1076-1081.
28. Feske S: Calcium signaling in lymphocyte activation and disease. Nat Rev Immunol 2007; 7:690-702.
29. Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA: Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 2006; 56:135-144.
30. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, Romero R: Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001; 185:792-797.
31. Hojo M, Suthanthiran M, Helseth G, August P: Lymphocyte intracellular free calcium concentration is increased in preeclampsia. Am J Obstet Gynecol 1999; 180:1209-1214.
32. von Dadelszen P, Wilkins T, Redman CW: Maternal peripheral blood leukocytes in normal and preeclamptic pregnancies. Br J Obstet Gynaecol 1999; 106:576-581.
33. Lee VM, Quinn PA, Jennings SC, Ng LL: Neutrophil activation and production of reactive oxygen species in pre-eclampsia. J Hypertens 2003; 21:395-402.
34. Zhu A, Romero R, Petty HR: An enzymatic uorimetric assay for pyruvate. Anal Biochem 2009; 396:146-151.
35. 2+ oscillations in differentiated U937 cells; a study using laser scanning confocal microscopy and co-loaded uo-3 and fura-red uorescent probes. Cell Calcium 1995; 18:377-389.
36. Kindzelskii AL, Huang J-B, Chaiworapongsa T, Kim YM, Romero R, Petty HR: Pregnancy alters glucose-6-phosphate dehydrogenase trafcking, cell metabolism and oxidant release of maternal neutrophils. J Clin Invest 2002; 110:1801-1811.
37. Segel GB, Cokelet GR, Lichtman MA: The measurement of lymphocyte volume: importance of reference particle deformability and counting solution tonicity. Blood 1981; 57:894-899.
38. Yasaka T, Mantich NM, Boxer LA, Baehner RL: Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol 1981; 127:1515-1518.
39. Matyushichev VB, Shamratova VG, Muzafarova DA: Correlation between the quantity of white blood cells and their volume distribution parameters in humans. Hum Physiol 2001; 27:110-114.
40. Pitkin RM, Witte DL: Platelet and leukocyte counts in pregnancy. JAMA 1979; 242:2696-2698.
41. Balloch AJ, Cauchi MN: Reference ranges for haematology parameters in pregnancy derived from patient populations. Clin Lab Haematol 1993; 15:7-14.
42. Harvery JW, Asquith RL, Pate MG, Kivipelto J, Chen CL, Ott EA: Haematological ndings in pregnant, postparturient and nursing mares. Comp Haematol Int 1994; 4:25-29.
43. Weber G: Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage. Proc Natl Acad Sci USA 1969; 63:1365-1369.
44. Davies SE, Brindle KM: Effects of overexpression of phosphofructokinase on glycolysis in the yeast Saccharomyces cerevisiae. Biochemistry 1992; 31:4729-4735.
45. Urbano AM, Gillham H, Groner Y, Brindle KM: Effects of overexpression of the liver subunit of 6-phosphofructo-1-kinase on the metabolism of a cultured mammalian cell line. Biochem J 2000; 352 (Pt 3):921-927.
46. Pearce AK, Crimmins K, Groussac E, Hewlins MJ, Dickinson JR, Francois J, Booth IR, Brown AJ: Pyruvate kinase (Pyk1) levels inuence both the rate and direction of carbon ux in yeast under fermentative conditions. Microbiology 2001; 147 (Pt 2):391-401.
47. Moore PA, Bettany AJ, Brown AJ: Multiple copies of the pyruvate kinase gene affect yeast cell growth. J Gen Microbiol 1990; 136:2359-2366.
48. Mathews CK, van Holde KE: Biochemistry. Redwood City, CA, Benjamin /Cummings, 1990.
49. Mathupala SP, Colen CB, Parajuli P, Sloan AE: Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis. J Bioenerg Biomembr 2007; 39:73-77.
50. Roos D, Balm AJM: The oxidative metabolism of monocytes. In The Reticuloendothelial System: A Comprehensive Treatise, Vol. 2, AJ Sabarra, RR Strauss (eds). NY, Plenum Press, 1980, pp 189-229.
51. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC: Glucose metabolism in lymphocytes is a regulated process with signicant effects on immune cell function and survival. J Leukoc Biol 2008; 84:949-957.
52. Berman BG, Halperin ML: Effect of insulin on pyruvate metabolism in epididymal adipose tissue of the rat. Correlation of intracellular pyruvate contents and pyruvate dehydrogenase activity. Biochem J 1973; 134:885-889.
53. 2+ release in rats via mitochondria-dependent and -independent mechanisms. J Physiol 2003; 550(Pt 3):765-783.
54. + T cells. J Immunol 2002; 168:3825-3832.
55. Leitenberg D, Bottomly K: Regulation of naïve T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999; 11:283-292.
56. Karlsson A, Dahlgren C: Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 2002; 4:49-60.
57. Sacks GP, Studena K, Sargent K, Redman CW: Normal pregnancy and preeclampsia both produce inammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80-86.
58. Ramanathan S, Masih AK, Ashok U, Arismendy J, Turndorf H: Concentrations of lactate and pyruvate in maternal and neonatal blood with different intravenous uids used for prehydration before epidural anesthesia. Anesth Analg 1984; 63:69-74.
59. Aynsley-Green A, Soltesz G, Jenkins PA, Mackenzie IZ: The metabolic and endocrine milieu of the human fetus at 18-21 weeks of gestation. II. Blood glucose, lactate, pyruvate and ketone body concentrations. Biol Neonate 1985; 47:19-25.
60. Cetin I, de Santis MS, Taricco E, Radaelli T, Teng C, Ronzoni S, Spada E, Milani S, Pardi G: Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol 2005; 192:610-617.
61. Soltesz G, Harris D, Mackenzie IZ, Aynsley-Green A: The metabolic and endocrine milieu of the human fetus and mother at 18-21 weeks of gestation. I. Plasma amino acid concentrations. Pediatr Res 1985; 19:91-93.
62. Glew RH, Melah G, El-Nafaty AI, Brandt Y, Morris D, VanderJagt DJ: Plasma and urinary free amino acid concentrations in preeclamptic women in northern Nigeria. Clin Chim Acta 2004; 342:179-185.
63. Evans RW, Powers RW, Ness RB, Cropcho LJ, Daftary AR, Harger GF, Vergona R, Finegold DN: Maternal and fetal amino acid concentrations and fetal outcomes during pre-eclampsia. Reproduction 2003; 125:785-790.
64. White A, Handler P, Smith EL: Principles of Biochemistry, 5th edn. NY, McGraw-Hill, 1973.
65. +, and pyruvate. Biochemistry 1994; 33:6301-6309.
66. Takada G, Ohtake M, Miyabayashi S, Narisawa K, Tada K: Pyruvate carboxylase activity in lymphoblasts. J Inherit Metab Dis 1982; 5:69-70.
67. Mahiout A, Matata BM, Brunkhorst R: Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis uids on leukocytes cell functions. Kidney Int 1997; 51:860-867.
68. Mahiout A, Brunkhorst R: Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 1995; 10:391-394.
69. Oehler R, Weingartmann G, Manhart N, Salzer U, Meissner M, Schlegel W, Spittler A, Bergmann M, Kandioler D, Oismuller C, Struse HM, Roth E: Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 2000; 95:1086-1092.
70. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ: Lactic acidosis during sepsis is related to increased pyruvate production, not decits in tissue oxygen. Ann Surg 1996; 224:97-102.
71. Carboné P, Sobreviela M, Jimenez D, Martínez C, Gonzalez de Agüero R, Pocoví M: Maternal leukocyte metabolism during pregnancy and puerperium, and its relation to fetal growth. Acta Obstet Gynecol Scand 1992; 71:266-272.
72. Pizzuto R, Paventi G, Atlante A, Passarella S: Pyruvate kinase in pig liver mitochondria. Arch Biochem Biophys 2010; 495:42-48.
73. Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E: Pyruvate kinase type M2: a crossroad in the tumor metabolome. Br J Nutr 2002; 87(Suppl 1):S23-S29.
74. Oggé G, Romero R, Chaiworapongsa T, Gervasi MT, Pacora P, Erez O, Kusanovic JP, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Mittal P, Kim YM, Hassan SS: Leukocytes of pregnant women with small-forgestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med 2009 November (Early Online 1-2).
75. Kim SK, Romero R, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Mittal P, Erez O, Vaisbuch E, Gotsch F, Pacora P, Yeo L, Gervasi MT, Lamont RF, Yoon BH, Hassan SS: Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inammatory response syndrome. J Perinat Med 2009; 37:543-552.
76. Gervasi MT, Chaiworapongsa T, Naccasha N, Blackwell S, Yoon BH, Maymon E, Romero R: Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol 2001; 185:1124-1129.
77. Gervasi MT, Chaiworapongsa T, Naccasha N, Pacora P, Berman S, Maymon E, Kim JC, Kim YM, Yoshimatsu J, Espinoza J, Romero R: Maternal intravascular inammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11:171-175.
78. Zhu A, Romero R, Petty HR: An enzymatic uorimetric assay for glucose-6-phosphate: application in an in vitro Warburg-like effect. Anal Biochem 2009; 388:97-101.